Safety Modeling and Profiling, Immune-Related Adverse Events
Learn about the cutting edge of computational immuno-oncology through a partnership between NCI and the Society for Immunotherapy of Cancer (SITC)!
Join Dr. Marcelo Pasquini of the Medical College of Wisconsin and Dr. Alan Hutson of the Roswell Park Comprehensive Cancer Center as they discuss their understanding and prediction of adverse immune reactions associated with medical interventions, such as immunotherapy and immune-modulating drugs.
This webinar explores the development of safety models (using diverse data sources) to identify potential risk factors and patterns of immune-related adverse events, including:
- genetic markers,
- immune system profiling, and
- patient histories.
The SITC-NCI Computational Immuno-Oncology Webinar Series features eight, one-hour-long webinars designed to educate early-career scientists on computational immuno-oncology, increase participants’ awareness of and engagement in NCI-supported Cancer MoonshotSM Immunotherapy Networks, and fulfill the Blue Ribbon Panel’s goal of accelerating progress in cancer research.
Dr. Pasquini is a professor at the Medical College of Wisconsin. His clinical focus is on the treatment of patients with hematologic malignancies, largely multiple myeloma.
Dr. Hutson serves as chair of the Biostatistics and Bioinformatics Department and associate director of the Biostatistics and Statistical Genomics Shared Resource at Roswell Park Comprehensive Cancer Center.
Upcoming Events
- HLA-Arena: Enabling Structure-Guided Pipelines for Personalized Cancer Immunotherapy DesignApril 30, 2025AI-Driven Spatial Transcriptomics Unlocks Large-Scale Breast Cancer Biomarker Discovery from HistopathologyMay 07, 2025Co-clinical Imaging Research Resource Program (CIRP) Annual Virtual Meeting 2025—Celebrating A Ten-Year MilestoneMay 07, 2025 - May 08, 2025Agentic AI in Cancer ResearchMay 27, 2025BTEC 2025 Annual Conference: The Epidemiology of Brain Metastases for Adult and Pediatric Brain TumorsMay 29, 2025Ctrl+Alt+Cure: Driving Smarter Cancer CareJune 11, 2025